Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip

ClinicalTrials.gov ID: NCT00541489

Public ClinicalTrials.gov record NCT00541489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To study the efficacy and safety of Naproxcinod vs. Placebo and Naproxen in the treatment of signs and symptoms of Osteoarthritis.

Study identification

NCT ID
NCT00541489
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NicOx
Industry
Enrollment
800 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2007 (Type not available)
Primary completion
Sep 2008 (Actual)
Completion
Not listed
Last update posted
Feb 20, 2009

Started 2007

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Not listed Mobile Alabama 36608 —
Not listed Montgomery Alabama 36106 —
Not listed Tuscaloosa Alabama 35406 —
Not listed Chandler Arizona 85224 —
Not listed Mesa Arizona 85213 —
Not listed Phoenix Arizona 85016 —
Not listed Fair Oaks California 95628 —
Not listed San Diego California 92120 —
Not listed Santa Barbara California 93111 —
Not listed Northglenn Colorado 80234 —
Not listed Coral Gables Florida 33134 —
Not listed Daytona Beach Florida 32117 —
Not listed DeLand Florida 32720 —
Not listed Fort Meyers Florida 33916 —
Not listed Jupiter Florida 33458 —
Not listed Louisville Kentucky 40291 —
Not listed Peabody Massachusetts 01960 —
Not listed Kalamazoo Michigan 49009 —
Not listed Saginaw Michigan 48602 —
Not listed Berlin New Jersey 08009 —
Not listed Dover New Jersey 07801 —
Not listed Rochester New York 14609 —
Not listed Cincinnati Ohio 45224 —
Not listed Cleveland Ohio 44122 —
Not listed Franklin Ohio 45005 —
Not listed Bethany Oklahoma 73008 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Penndel Pennsylvania 19047 —
Not listed Warwick Rhode Island 02886 —
Not listed Anderson South Carolina 29621 —
Not listed Columbia South Carolina 29204 —
Not listed Kingsport Tennessee 37660 —
Not listed Austin Texas 78705 —
Not listed Nederland Texas 77627 —
Not listed San Antonio Texas 78217 —
Not listed Newport News Virginia 23606 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00541489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2009 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00541489 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →